Excellent
Fully Aligned
Patient Risk:
Low
Summary
The evaluated claim exactly matches the FDA label contraindication for LINZESS in patients less than 2 years of age due to the risk of serious dehydration, with consistent supporting context across Sections 4, 5.1, and 8.4.
Category Scores
Accurate Statements
LINZESS is contraindicated in patients less than 2 years of age due to the risk of serious dehydration.
Label Sections 4, 5.1, and 8.4 state LINZESS is contraindicated in patients <2 years of age due to the risk of serious dehydration.
Unsupported Statements
Contradictions
Important Omissions
Safety Assessment
Potential Patient Risk:
Low
The statement reflects an explicit contraindication in the FDA label for the specified age group and does not introduce conflicting or unsupported safety information.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Fully Aligned
Primary Issue
Suggested Improvement